Kathleen Nicholls

University of Melbourne

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Collaborators (7)

Michael Walsh

Associate Professor

McMaster University

CANADA

View details

Rachel Jones

University of Cambridge

UNITED KINGDOM

View details

Han Chung Lee

Monash University Malaysia.

AUSTRALIA

View details

Gary Hoffman

Former Chairman, Professor

Cleveland Clinic

UNITED STATES

View details

Catherine Quinlan

University of Melbourne

AUSTRALIA

View details

Raphaele Seror

Université Paris-Saclay

FRANCE

View details

Sharon Ricardo

Professor and Lab Head

MONASH UNIVERSITY

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kathleen Nicholls

Research Interests

Explore related searches

Contact this professor

Articles (10)

Mutation-Specific Cardiomyocyte Lines from Patients with Fabry Disease: A Sustainable In Vitro Model to Investigate Structure, Function, and Disease Mechanisms

Investigating lysosomal dysfunction in Fabry disease using induced pluripotent stem cell-derived podocytes

Enhancing diagnostic outcomes in kidney genetic disorders: the KidGen national kidney genomics study protocol

Safety analysis of self-administered enzyme replacement therapy using data from the Fabry Outcome and Gaucher Outcome Surveys

Genetic Kidney Disease Across the Lifespan – Emerging Insights From Clinical Genomics in Older People

Two decades of experience of the Fabry Outcome Survey provides further confirmation of the long-term effectiveness of agalsidase alfa enzyme replacement therapy

Sodium-glucose cotransporter 2 inhibitors reduce albuminuria in patients with Fabry disease: a real-world case series

Fabry Disease Podocytes Reveal Ferroptosis as a Potential Regulator of Cell Pathology

Isaralgagene civaparvovec (ST-920) gene therapy in adults with Fabry disease: Updated results from an ongoing phase 1/2 study (STAAR)

Risk of Relapse of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in a Randomized Controlled Trial of Plasma Exchange and Glucocorticoids

Collaborators (7)

Michael Walsh

Rachel Jones

Han Chung Lee

Gary Hoffman

Catherine Quinlan

Raphaele Seror

Sharon Ricardo

Make your next move.